Table 2.
The data of patients according to the type of PGD
| MCD (n = 259) |
FSGS (n = 848) |
MN (n = 992) |
IgAN (n = 995) |
Mes. PGN (n = 97) |
MPGN (n = 349) |
Acute PGN (n = 31) |
CGN (n = 244) |
|
|---|---|---|---|---|---|---|---|---|
| Age Mean ± SD | 36.1 ± 15.4 | 40.4 ± 14.2 | 46.7 ± 14.5 | 38.4 ± 13 | 36.8 ± 13.8 | 37.3 ± 15.6 | 43.1 ± 17.2 | 48 ± 16.6 |
| Gender n (%) Woman | 118 (45.9) | 415 (48.9) | 409 (41.3) | 371 (37.3) | 56 (58.9) | 168 (48.3) | 13 (40.6) | 112 (45.5) |
| Creatinine (mg /dL) Mean ± SD | 0.89 ± 0.65 | 1.29 ± 1.17 | 1 ± 0.8 | 1.55 ± 1.26 | 0.97 ± 0.69 | 1.51 ± 1.41 | 2.23 ± 2.22 | 4.1 ± 3.34 |
|
eGFR (CKD-EPI) mL/min Mean ± SD |
105 ± 33 | 82 ± 36 | 94 ± 33 | 72 ± 36 | 99 ± 33 | 77 ± 40 | 62 ± 43 | 30 ± 30 |
| Serum albumin (g/dL) Mean ± SD | 2.61 ± 1.03 | 3.39 ± 0.93 | 2.77 ± 0.86 | 3.85 ± 0.69 | 3.52 ± 0.9 | 3.15 ± 0.89 | 3.19 ± 0.85 | 3.24 ± 0.73 |
| Proteinuria (mg/day) Median (IQR) | 5835 (2400–9000) | 3400 (1770–5740) | 6000 (3400–9280) | 1822 (1000–3400) | 1600 (540–3900) | 3500 (1400–6120) | 2310 (900–7435) | 2100 (1230–3690) |
| Hematurian n (%) | 47 (18.2) | 277 (32.6) | 288 (29.1) | 633 (63.7) | 42 (43.8) | 170 (48.7) | 22 (68.8) | 191 (77.6) |
| Pyurian (%) | 31 (13.5) | 113 (15.2) | 115 (13.2) | 178 (20.0) | 15 (18.8) | 83 (31.4) | 8 (28.6) | 92 (41.1) |
| SBP (mmHg) Mean ± SD | 122 ± 17 | 131 ± 19 | 129 ± 19 | 130 ± 21 | 129 ± 25 | 132 ± 23 | 142 ± 23 | 136 ± 20 |
| DBP (mmHg) Mean ± SD | 76 ± 10 | 81 ± 11 | 81 ± 11 | 82 ± 12 | 81 ± 15 | 82 ± 13 | 84 ± 13 | 82 ± 11 |
Abbreviations: Acute PGN acute proliferative glomerulonephritis, CGN crescentic glomerulonephritis, DPB diastolic blood pressure, eGFR estimated glomerular filtration rate, FSGS Focal segmental glomerulosclerosis, IgAN IgA nephropathy, MCD minimal change disease, Mes.PGN Mesangioproliferative glomerulonephritis (non-IgA), MN membranous nephropathy, MPGN membranoproliferative glomerulonephritis, SPB systolic blood pressure, PGD primary glomerular disease